US Patent Issued to Arisan Therapeutics on March 4 for "Adamantane derivatives for the treatment of filovirus infection" (California Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,857, issued on March 4, was assigned to Arisan Therapeutics Inc. (Carlsbad, Calif.).

"Adamantane derivatives for the treatment of filovirus infection" was invented by Michael Bruno Plewe (San Diego), Eric Brown (San Diego), Vidyasagar Gantla (San Diego), Gregory Henkel (San Diego), Kenneth McCormack (San Diego) and Nadezda Sokolova (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of structural Formula I were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus, wherein, R1, R2, R3, X and Y are defined in the specification."

The patent was filed on July 12, 2018, under Application No. 16/0...